Delayed manifestation of COVID-19 presenting as lower extremity multilevel arterial thrombosis: a case report
Open Access
- 19 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 4 (6), 1-4
- https://doi.org/10.1093/ehjcr/ytaa371
Abstract
Venous thrombo-embolic events have been described in hospitalized patients with coronavirus disease 2019 (COVID-19), suggesting the presence of coagulopathy induced by the viral infection. To date, only rare cases of arterial thrombosis related to COVID-19 have been reported. A 54-year-old patient with an influenza-like illness 15 days earlier, which resolved, and no known cardiovascular risk factor presented with acute right lower limb ischaemia. A computed tomography angiogram of the abdominal aorta and lower extremities showed, in the absence of vascular disease, a subocclusive thrombosis of the right common iliac artery and an occlusion of the right internal iliac, profunda femoral, and popliteal arteries. On the left side, the computed tomography angiogram demonstrated a non-occlusive thrombosis of the common femoral artery. The patient underwent emergency surgical thrombectomy as well as endovascular revascularization on the right side followed by therapeutic anticoagulation, with normalization of the limb perfusion. A nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by real-time reverse transcription–PCR (rRT–PCR) was negative three times. Haemostasis analysis showed a mild hyperfibrinogenaemia and a shortening of the activated partial thromboplastin time. An extensive screening for cardio-embolism was negative. As the thrombotic event was unexplained, antibody testing for SARS-CoV-2 was performed and the result was positive. Venous thrombosis and pulmonary embolisms have been observed in COVID-19. As in our case, the first reports on COVID-19-associated arterial thrombotic events have emerged. A better understanding of the coagulopathy in COVID-19 is essential to guide prevention and treatment of venous as well as arterial thrombo-embolic events.Keywords
This publication has 12 references indexed in Scilit:
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19Annals of Internal Medicine, 2020
- Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Coagulopathy of COVID‐19 and antiphospholipid antibodiesJournal of Thrombosis and Haemostasis, 2020
- High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patientsJournal of Thrombosis and Haemostasis, 2020
- Acute aorto‐iliac and mesenteric arterial thromboses as presenting features of COVID‐19British Journal of Haematology, 2020
- Acute upper limb ischemia in a patient with COVID-19Hematology/Oncology and Stem Cell Therapy, 2020
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort studyIntensive Care Medicine, 2020
- Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection.2020
- Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumoniaRadiology Case Reports, 2020
- Procoagulant activity during viral infectionsFrontiers in Bioscience-Landmark, 2018